Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.31%
#2 aelf aelf +23.02%
#3 Venom Venom +14.28%
#4 Bitway Bitway +13.63%
#5 Pons Pons +10.65%
#6 Decred Decred +10.50%
#7 TRIA TRIA +9.66%
#8 Wibx Wibx +8.12%
#9 AtomOne AtomOne +7.63%
#10 DexNet DexNet +7.56%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Vectorite Biomedical Inc. Vectorite Biomedical Inc.

Vectorite Biomedical Inc.

4170
Clasificación en acciones #30413
Vectorite Biomedical Inc., established in 1993 and based in New Taipei City,... Vectorite Biomedical Inc., established in 1993 and based in New Taipei City, Taiwan, is a biotechnology firm dedicated to research and development activities globally, including a strong presence in its home country. The company's operations encompass the manufacturing of specialized cell preparation products, in addition to providing full-spectrum services for the collection, processing, and secure storage management of immune cells. These advanced cellular preparations are vital for applications in the medical fields of infectious diseases, inflammatory conditions, and various oncological and tumor-related illnesses.
Precio por acción
$0.392718
Capitalización bursátil
$17.19M
Cambio (1 día)
0.00%
Cambio (1 año)
-8.65%
País
TW
Comercio Vectorite Biomedical Inc. (4170)

Categoría

Healthcare
Ganancias de Vectorite Biomedical Inc. (4170)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Vectorite Biomedical Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Vectorite Biomedical Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE